Close Menu

NEW YORK (GenomeWeb) – Cypress, California-based DiaSorin Molecular said today that it has received CE marking for its Simplexa HSV 1/2 & VZV Universal Direct MDx assay designed for use on the firm's Liaison MDx instrument.

The assay uses cutaneous and mucocutaneous swab specimens for the direct detection and differentiation of DNA associated with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus (VZV).

Testing for VZV with HSV-1 and HSV-2 may enable clinicians to provide improved therapeutic decisions and advice, DiaSorin said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.